Paragon Biosciences: Funding, Investors & Team (Oct 2026)
A pioneer in life sciences, Paragon founds, finances, and develops bioscience businesses. We overcome difficult problems by developing science. The four areas of life science innovation that Paragon focuses on include biopharmaceuticals, gene therapy, synthetic biology, and artificial intelligence. Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, Skyline Biosciences, and a steady stream of developing incubating startups make up our current portfolio. At the nexus of human need, life science, and business creation is Paragon.
Paragon Biosciences has raised $185M across 1 funding round on record, the most recent an undisclosed round of $185M announced in Nov 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Paragon Biosciences Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Paragon Biosciences Funding Rounds
Paragon Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Paragon Biosciences Funding Compared to Other Biotechnology Startups
Paragon Biosciences' latest round of $185M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Paragon Biosciences in Biotechnology and Chicago
Companies Similar to Paragon Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Paragon Biosciences Funding FAQs
What does Paragon Biosciences do?
A pioneer in life sciences, Paragon founds, finances, and develops bioscience businesses. We overcome difficult problems by developing science. The four areas of life science innovation that Paragon focuses on include biopharmaceuticals, gene therapy, synthetic biology, and artificial intelligence. Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, Skyline Biosciences, and a steady stream of developing incubating startups make up our current portfolio. At the nexus of human need, life science, and business creation is Paragon.
How much funding has Paragon Biosciences raised?
Paragon Biosciences has raised $185M across 1 round on record. The most recent is an undisclosed round of $185M announced in Nov 2022.
When did Paragon Biosciences last raise funding?
Paragon Biosciences' most recent funding round on record is an undisclosed round of $185M, announced in Nov 2022.
Who is the CEO of Paragon Biosciences?
Jeffrey Aronin is listed as CEO at Paragon Biosciences.
Where is Paragon Biosciences headquartered?
Paragon Biosciences is based in Chicago, Illinois, United States.
How many employees does Paragon Biosciences have?
Paragon Biosciences is in the 11-50 employee band.
How does Paragon Biosciences' funding compare to other Biotechnology startups?
Paragon Biosciences' latest round of $185M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Paragon Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Paragon Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.